Eligible commercially insured patients† and uninsured cash-paying patients are responsible for paying out-of-pocket expenses noted below and any amount that exceeds the Galderma payment for each prescription, as follows:
AKLIEF® (trifarotene) Cream, 0.005%
Product Size: 45 g pump
†Galderma CareConnect is only available for commercially insured or uninsured patients. Patients who are enrolled in a government-run or government-sponsored healthcare plan with a pharmacy benefit are not eligible to use the Galderma CareConnect Patient Savings Card.
The Galderma® CareConnect Program is brought to you by Galderma Laboratories, L.P. The Patient Savings Card provides savings on out‑of‑pocket expenses for up to a 30‑day supply of included Galderma products. If you have valid prescriptions for more than one Galderma product, the copay expense and savings apply to each product. You may use the Patient Savings Card once every 30 days, depending on when you last received a 30‑day supply of each Galderma product. Use of the Patient Savings Card does not obligate you to use or to continue using any Galderma product. You may use the Patient Savings Card at any participating pharmacy located in the United States.
The Galderma CareConnect Program Patient Savings Card may not be combined with any savings, discount, free trial, or other similar offer for the same prescription. The Patient Savings Card is not transferable and is void if reproduced. The Patient Savings Card is not health insurance. Limit one (1) Patient Savings Card per patient. The Galderma CareConnect Program Patient Savings Card has no cash value and will not be accepted outside of participating pharmacies in the United States. Please visit Galderma’s website for our privacy practices. Galderma reserves the right to revoke or amend this offer without notice at any time and to deny payment for noncompliance with the terms of this offer.
Use of this Patient Savings Card is subject to applicable state and federal law, and is void where prohibited by law, rule or regulation. In the event an AB rated generic equivalent product becomes available for one of the Galderma products covered by this Patient Savings Card, this offer will become void in Massachusetts with respect to that Galderma product.
By using the Galderma CareConnect Program Patient Savings Card, you acknowledge that you currently meet the following eligibility criteria:
You have a valid prescription for the Galderma product your copay and the savings apply to;
You have no insurance or are subject to a private insurance copay Requirement for your prescription;
You are not enrolled in Medicare Part D, Medicaid, Medigap, VA, DOD, Tricare, or any other government-run or government sponsored health care program with a pharmacy benefit;
You are at least 18 years old; and
You reside in the United States.
Are you 18 years or older?
(IF NOT 18 YEARS OR OLDER, YOU WILL BE RETURNED TO THE PAGE)
Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Warnings/Precautions: Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of treatment, and, if appropriate, depending upon the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin. Use of “waxing” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
IMPORTANT SAFETY INFORMATION
Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid
indicated for the topical treatment of acne vulgaris in patients 9 years of age
and older. Adverse Events: The most common adverse reactions
(incidence ≥ 1%) in patients treated with AKLIEF Cream were application site
irritation, application site pruritus (itching), and sunburn.
Warnings/Precautions: Patients using AKLIEF Cream may experience erythema,
scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of
treatment, and, if appropriate, depending upon the severity of these adverse reactions,
reduce the frequency of application of AKLIEF Cream, suspend or discontinue use.
Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin.
Use of “waxing” as a depilatory method should be avoided on skin treated with
AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective
clothing over treated areas when exposure cannot be avoided.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit
www.fda.gov/medwatch or call 1-800-FDA-1088.
